A number of stocks fell in the afternoon session after industry bellwether UnitedHealth Group (UNH) slashed its 2025 profit ...

Key Insights Bruker's estimated fair value is US$48.33 based on 2 Stage Free Cash Flow to Equity Current share price ...

In this article, the Technology Networks team chatted with various experts at ASMS 2025 about what they believe will be ...

Sarepta says it will continue to ship Elevidys despite FDA requests that it stop shipments of the Duchenne muscular dystrophy gene therapy, while Verizon tops earnings expectations and raises 2025 ...

Find insight on Bruker, Sartorius, Sarepta and more in the latest Market Talks covering Health Care.

Shares of scientific instrument company Bruker (NASDAQ:BRKR). fell 13.8% in the afternoon session after the company released ...

Bruker Corporation (NASDAQ:BRKR) saw its shares drop 8.75% in premarket trading Monday following the release of preliminary second-quarter figures that showed flat reported revenue and a decline in ...

Shares of Bruker fell after the company reported preliminary second-quarter results that missed Wall Street's expectations, hurt by what it called weak academic demand and a soft biopharma market in ...

The company announced preliminary revenue for the second quarter ended June 30, 2025, in a range of $795-$798 million, which is approximately flat on a reported basis compared to the same period last ...

Homeostatic plasticity, the brain's method of preserving equilibrium in neural circuits, relies heavily on spontaneous ...